| Objetive:To investigate effect of sufentanil administered locally on median effective concentration ropivacaine for thoracic paravertebral block.Methods:Sixty patients with lung disease,aged 30-65years,ASA I or III,no gender and BMI 1828kg/m2,scheduled for lobectomy under video-assisted thoracoscopic surgery,requiring ultrasound-guided thoracic paravertebral block at the level of T4-5andT5-6.All the patients were randomly assigned into 2 groups:Control group(group C)and Test group(group T).Paravenebral block was performed by using only ropivacaine in groupC.In groupT the mixture of ropivacaine and 0.6ug/ml sufentanil was injected for the block.The concentration of ropivacaine is determined by the up-and-down sequential method.The initial concentration of ropivacaine was0.5%and the ratio between the two successive concentrations was 1.2.If the block was effective.The next patient received a lower dose of ropivacaine,or if ineffective,a higher dose was given to the next patient.End point of study was 7 up-and-down cycles or ropivacaine concentration≤0.1%or≥1%,and continued for 7 cases.The EC500 and 95%confidence interval(CI)of ropivacaine were determined by using the formula of Dixion-Massey sequential method.The nerve block-related complications and VAS scores,HR,MAP at 4h(T1),6h(T2),8h(T3),12h(T4),24h(T5)after surgery in the two groups,the total amount of ropivacaine and opioids during the operation,the users of additional analgesic drugs were recorded.Results:The EC50 of ropivacaine was 0.41%and 95%CI was 0.39%0.43%in group C,The EC50 of ropivacaine was 0.33%and 95%CI was 0.31%0.35%in group T.Compared with group C,the VAS scores,HR and MAP of group T at 8h and 12h after surgery were significantly reduced(P<0.05).The total amount of ropivacaine and were significantly reduced(P<0.05);Nausea occurred in 2 patients(9.5%)and vomiting in 1 patient(4.8%)in group T;no adverse reactions related to nerve block occurred in patients in group C;There was no significant difference in the total amount of opioids during the two groups.Conclusions:The combined use of sufentanil can decrease the EC50 of ropivacaine for ultrasound-guided thoracic paravertebral block. |